Blog

SPOT-MAS NEWS

Current cancer screening methods are predominantly organ specific, utilizing diagnostic imaging tests with multiple modalities.
Cell free DNA (cfDNA)-based assays hold great potential in detecting early cancer signals. However, predicting the tissue-of-origin for multiple cancer types at an early stage remains challenging due to the low abundance of tumor- derived cfDNA and the confounding presence of various DNA components released from non- tumor sources.

Gene Solutions News

SPOT-MAS video